TY  - JOUR
AU  - Díaz Navarro, Marta
AU  - Cercenado Mansilla, Emilia
AU  - Monte, Ariadna
AU  - Visedo, Andrés
AU  - Rodríguez, Carmen
AU  - Pérez Granda, María Jesús
AU  - Muñoz García, Patricia Carmen
AU  - Guembe, María
PY  - 2025
DO  - 10.1016/j.heliyon.2025.e41885
SN  - 2405-8440
UR  - https://hdl.handle.net/20.500.14352/119223
T2  - Heliyon
AB  - BackgroundOritavancin (ORT) is a new single-dose lipoglycopeptide showing in vitro activity against staphylococci and vancomycin-resistant enterococci. However, there is no data regarding its potential use as a catheter lock solution are scarce. We...
LA  - eng
M2  - 1
PB  - Elsevier Ltd
KW  - Oritavancin
KW  - Catheter lock solution
KW  - Catheter-related bloodstream infection
KW  - Activity
KW  - Stability
TI  - Is an oritavancin catheter lock solution active against biofilms of staphylococci and enterococci?
TY  - journal article
VL  - 11
ER  -